Literature DB >> 9523536

Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells.

D J Granville1, J G Levy, D W Hunt.   

Abstract

Treatment with benozopophyrin derivative monoacid ring A (BPD-MA, verteporfin) and broad-spectrum fluorescent light rapidly produced apoptosis in murine P815 mastocytoma cells. Fragmentation of DNA, a fundamental characteristic of cells undergoing apoptosis, was evident within 3 h following the photodynamic treatment. Western immunoblot analysis using the specific antiphosphotyrosine monoclonal antibody 4G10 indicated that molecular species of > 200 kDa were phosphorylated on tyrosine residues during or immediately following the irradiation of cells loaded with BPD-MA. Increased tyrosine phosphorylation of a 15 kDa protein was evident by 15 min postirradiation. In the absence of light, BPD-MA did not affect the status of cellular protein tyrosine phosphorylation or cause DNA fragmentation. The protein kinase inhibitor staurosporine prevented tyrosine phosphorylation of the > 200 kDa species but did not affect tyrosine phosphorylation of the 15 kDa protein or the level of DNA fragmentation produced by the photodynamic treatment. The protein tyrosine phosphorylation events observed for P815 cells treated with cytotoxic levels of BPD-MA and light may not be directly related to the induction of the apoptotic cell death pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523536

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  9 in total

1.  Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.

Authors:  Galina G Kramarenko; Werner W Wilke; Disha Dayal; Garry R Buettner; Freya Q Schafer
Journal:  Free Radic Biol Med       Date:  2006-01-19       Impact factor: 7.376

2.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

3.  A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.

Authors:  Imran Rizvi; Shubhankar Nath; Girgis Obaid; Mustafa Kemal Ruhi; Kaitlin Moore; Shazia Bano; David Kessel; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2019-01-07       Impact factor: 3.421

4.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

Review 5.  Enhancement of anti-tumor immunity by photodynamic therapy.

Authors:  Sandra O Gollnick; Craig M Brackett
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

Review 6.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

7.  Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy.

Authors:  Edith Kabingu; Allan R Oseroff; Gregory E Wilding; Sandra O Gollnick
Journal:  Clin Cancer Res       Date:  2009-06-23       Impact factor: 12.531

8.  Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy.

Authors:  D J Granville; H Jiang; M T An; J G Levy; B M McManus; D W Hunt
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

9.  Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy.

Authors:  Sakkarapalayam M Mahalingam; Josue D Ordaz; Philip S Low
Journal:  ACS Omega       Date:  2018-06-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.